These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 3874911
41. Suppressive effect of portal venous inoculation with tumor cells on the anti-tumor immune potential. Kokudo S, Qian JH, Fujiwara H, Hamaoka T. Jpn J Cancer Res; 1987 Sep; 78(9):946-51. PubMed ID: 3117751 [Abstract] [Full Text] [Related]
42. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens. James SL, Lazdins JK, Hieny S, Natovitz P. J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456 [Abstract] [Full Text] [Related]
43. Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors. Czitrom AA, Sunshine GH, Reme T, Ceredig R, Glasebrook AL, Kelso A, MacDonald HR. J Immunol; 1983 Feb; 130(2):546-50. PubMed ID: 6600241 [Abstract] [Full Text] [Related]
44. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production. Guerne PA, Piguet PF, Vassalli P. J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845 [Abstract] [Full Text] [Related]
45. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay. Raina S, Russo AJ, Jenkins D, Goldrosen MH. Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811 [Abstract] [Full Text] [Related]
46. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells. Lespinats G, Poupon MF. Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185 [Abstract] [Full Text] [Related]
47. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M. J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [Abstract] [Full Text] [Related]
48. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system]. Ebina T, Shishido K, Murata K. Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138 [Abstract] [Full Text] [Related]
49. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. Williams RM, Germain RN, Benacerraf B. J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740 [Abstract] [Full Text] [Related]
50. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats. Kawase I, Komuta K, Namba M, Yokota S, Ogura T, Kishimoto S. Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719 [Abstract] [Full Text] [Related]
51. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. Deepe GS, Watson SR, Bullock WE. J Immunol; 1984 Apr; 132(4):2064-71. PubMed ID: 6230399 [Abstract] [Full Text] [Related]
52. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity. Komuta K, Kawase I, Ogura T, Masuno T, Yokota S, Hosoe S, Ikeda T, Shirasaka T, Kishimoto S. Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261 [Abstract] [Full Text] [Related]
53. Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen. Carter RH, Drebin JA, Schatten S, Perry LL, Greene MI. J Immunol; 1983 Feb; 130(2):997-1002. PubMed ID: 6184410 [Abstract] [Full Text] [Related]
54. Effector mechanism of tumor immunity in murine plasmacytoma. Chen YH, Anderson AB. Cancer Res; 1988 Mar 15; 48(6):1398-403. PubMed ID: 3257896 [Abstract] [Full Text] [Related]
55. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset. Nakajima H, Izumi Y, Sugihara S, Satoh Y, Isumi S, Gotoh T, Fujiwara H, Hamaoka T. Cancer Immunol Immunother; 1987 Mar 15; 25(3):201-8. PubMed ID: 3119213 [Abstract] [Full Text] [Related]
56. T-cell-mediated antitumor immune response induced by oncofetal antigens. Gautam S, Deodhar SD. J Natl Cancer Inst; 1981 Oct 15; 67(4):939-45. PubMed ID: 6974275 [Abstract] [Full Text] [Related]
57. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process. Igarashi T, Okada M, Kishimoto T, Yamamura Y. J Immunol; 1977 May 15; 118(5):1697-703. PubMed ID: 67145 [Abstract] [Full Text] [Related]
58. Dysfunction of Ia-positive antigen-presenting cells in tumor-bearing mice. Yamashita U. Jpn J Cancer Res; 1987 Mar 15; 78(3):261-9. PubMed ID: 3106282 [Abstract] [Full Text] [Related]
59. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study. Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA. Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805 [Abstract] [Full Text] [Related]
60. [Radiation effect on anti-tumor activity of C3H mouse spleen cells to MH134 hepatoma cells]. Nobusawa H, Hachisu R. Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Dec 25; 51(12):1481-8. PubMed ID: 1792156 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]